Ignite Creation Date:
2024-05-06 @ 3:15 PM
Last Modification Date:
2024-10-26 @ 1:46 PM
Study NCT ID:
NCT04572165
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
2024-01-02
First Post:
2020-09-30
Brief Title:
Epidemiological Assessment of the Risk for Pancreatic Cancer Associated With the Use of Semaglutide in Patients With Type 2 Diabetes - A Cohort Study Based on Nordic Registry Data
Sponsor:
Novo Nordisk AS
Organization:
Novo Nordisk AS
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-01-26
Start Date Type:
ACTUAL
Primary Completion Date:
2024-12-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2020-09-30
First Submit QC Date:
September 30 2020
Study First Post Date:
2020-10-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-12-29
Last Update Post Date:
2024-01-02
Last Update Post Date Type:
ACTUAL